form8k - sec.gov | home time to time, prime medical services, inc. makes presentations to the...

Download Form8k - SEC.gov | HOME time to time, Prime Medical Services, Inc. makes presentations to the investment community using slides containing the information attached to this Form 8-K

If you can't read please download the document

Upload: dinhliem

Post on 09-Mar-2018

215 views

Category:

Documents


1 download

TRANSCRIPT

-----BEGIN PRIVACY-ENHANCED MESSAGE-----Proc-Type: 2001,MIC-CLEAROriginator-Name: [email protected]: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQABMIC-Info: RSA-MD5,RSA, SCxJUZfWghm0Wf3gaI/UUYM+KU8ZRa9BinmRuprd+tpA3Qh4HYcWE9suTE1VtLUE KPDrvBGCmmQltgNMSnAbQg==

0000895810-03-000024.txt : 200311170000895810-03-000024.hdr.sgml : 2003111720031117162906ACCESSION NUMBER:0000895810-03-000024CONFORMED SUBMISSION TYPE:8-KPUBLIC DOCUMENT COUNT:26CONFORMED PERIOD OF REPORT:20031117ITEM INFORMATION:Other eventsFILED AS OF DATE:20031117

FILER:

COMPANY DATA:COMPANY CONFORMED NAME:PRIME MEDICAL SERVICES INC /TX/CENTRAL INDEX KEY:0000895810STANDARD INDUSTRIAL CLASSIFICATION:SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]IRS NUMBER:742652727STATE OF INCORPORATION:DEFISCAL YEAR END:1231

FILING VALUES:FORM TYPE:8-KSEC ACT:1934 ActSEC FILE NUMBER:000-22392FILM NUMBER:031008295

BUSINESS ADDRESS:STREET 1:1301 CAPITAL OF TEXAS HWYSTREET 2:SUITE C-300CITY:AUSTINSTATE:TXZIP:78746BUSINESS PHONE:5123282892

FORMER COMPANY:FORMER CONFORMED NAME:NEW PMSI INCDATE OF NAME CHANGE:19930112

8-K1form8k1117.htm

Form8k

November 17, 2003
PRIME MEDICAL SERVICES INC (PMSI)

form 8-K

Item 9. Regulation FDDisclosure.


Fromtime to time, Prime Medical Services, Inc. makes presentations to the investment communityusing slides containing the information attached to this Form 8-K as Exhibit 99.1. We arefurnishing the text of these slides pursuant to the Securities and ExchangeCommissions Regulation FD. This information is furnished pursuant to Item 9 of Form8-K and shall not be deemed to be filed for the purposes of Section 18 of theSecurities Exchange Act of 1934 or otherwise subject to the liabilities of that Section,unless we specifically incorporate it by reference in a document filed under theSecurities Act of 1933 or the Securities Exchange Act of 1934. By filing this report onForm 8-K and furnishing this information, we make no admission as to the materiality ofany information in this report that we choose to disclose solely because of Regulation FD.

Theinformation contained in the slides is summary information that is intended to beconsidered in the context of our SEC filings and other public announcements that we maymake, by press release or otherwise, from time to time. We undertake no duty or obligationto publicly update or revise the information contained in this report, although we may doso from time to time as our management believes is warranted. Any such updating may bemade through the filing of other reports or documents with the SEC, through press releasesor through other public disclosure.

Certainexpectations and projections regarding the future performance of the Company referenced inthis report are forward-looking statements. These expectations and projections are basedon currently available competitive, financial, and economic data, along with theCompanys operating plans and are subject to future events and uncertainties. Amongthe events and uncertainties which could adversely affect future periods are inability toestablish or maintain relationships with physicians and hospitals, healthcare regulatorydevelopments that prevent certain transactions with healthcare professionals orfacilities, inability of healthcare providers to obtain reimbursement for use of ourcurrent or future products, competition or technological change that impacts the marketfor our products, and difficulty in managing our growth. We caution readers that inaddition to the above cautionary statements, all forward-looking statements containedherein should be read in conjunction with the Companys SEC filings and other publicannouncements.


EX-99.13f8k1117.htm

GRAPHIC4slide1.gifGRAPHIC

begin 644 slide1.gifM1TE&.#EAT`(:F9R;GIV@GZ*AI*.FI:BGJJFLJZZML*^RL;2SMK6XMM[JP6XQ(OI2_OJ[#NN\M[NN]'IXMGNJDSM#`_O_KQV[LR8[LRZ[LS3Z>CF[ID%[ITP[MU$[IU8[MUZ[MMD\[MDN[ME_[MTI[MW0[NY2[NVQ[NT:[NUD[NY][NZS[NZ[L^Z[O_*C(*.CX.%D8@SC(2&DI".EY.*B9R+H9:CHJ6D_Z>FJ:BKJJVLKZZQL+.RMM;2WMKFXN[J]O+^^P&F7+PVX`/GX*DM56?9L8J-U1^`^26&UG^:)5B?@@PNZ&"#$#X(2X042ECAA19FB.&&&G;(X8:88EY8)IEHMGJG_9IILKNEFFZ/`^>:5?_)I):"#"JJEGX5B.:6AMBRJ*Z*&$0LKHHXT&ZFBDE29JZ:::5J/GIWB&"NJHHI8J)U,&@&"""BI4H0('M(,#*J@H&L+K"JQPI*=Z`#E_+`IRX5JE)W*M2?UC2G%D6`1T4JTZ4N50`[6()'MO_"A_P6P"D/PX0D.4+6P'7!6L6+7"H;@`E_5R@994\'RB%6M_\^=$@![.ZC!M1LDO:Y$KF.-RI2D=@*UT[BV3A%-!#EQ0N,F%C8B]XN$0=+`"%N)*62E,(0"RM13QR-3&;&(.GZ&Y'LF>E$&*BV\`K-V`RO%X/=AC`IFD_Y[#8N?.:7YPGQ6)+ML&*QUEG/TR//M-?;A`'L6'$U*;?A>K6.C!=SJHCB=`JC+?_"Q4I#)*NNQBI@_=(`'YC5K93UM%9-M4'$=,$`+;F4`OKJR:MJ+0#!9&\I+E62$5L>#%/WKP1!9.;?;ML"E:E[1]E!@`L'BL6`LWGJY>M.N>M7:&B=J>`T78IDM&SC2ZO;=R'-WLUH[JMCM$]U*L^**21Q\^#:2^WL2W6U[TNC"]X(=WT1:EXEY#>)9C7HPEP_\(21/]KMS!O\O2?]=>9'NH.>VC?>^A5X3---;I>ZNZCQUO;`1=P#W/?@P=\M\%)U\.T!MTW3?5M7V3R>J8=MGWJ(>-6^%1_I@%.]>^37]_%:[L.*E6/RL5P.6O8JN@A,LMDE4=T!4C$1CR'-\J@>EL8LR;Y2T,.&_);@LC$L5U2FIAC`-TA2U%=SA3,U9TM0U:PPG1AIBPVA"T!-#==8P!$]RJ2HTH0""YTYDIBI@(ZT$L[$$4M5RW-DR]GM%X`,XU:[S%6QI3A1V9C_,X#![E!.Y6>AI%42XIM>F58BEU`>L0F>]"F!:4HD>T5E9)JF3\TBC],87'4^):10XVW8DE#M5F9B8P`VH*-$UY=V67\J!(`0B'*6;$:(412=R5?!+IAG_BVX)5T2T+K&X`CF05AS8B.CX-JD9E0/EE_9ME(C-FT.BF\-IFX]$&_-I_^BV693GPA\U8=NX,5YMY]63.(E1(P5B]*5Z+!5N1LR&H*=]7L!]>R=5&J.!P@``/*I[I2-3LVM='-SL_:W/-;4-Z.%L?*(PL#`D`MPM@WCRWFW/)LU6DZCR\\U,3-3,/G4S:.SMCW>G,G?D3B`PP1,%QEV[>9I'5;X:SS&LAE3'P$5K+)PV/;W%1@\_WF5]U$165'#5L$OG-JCMP0>:EX+Y\XCE:DM8`5.=8E2S-`1M:E\"(&V6.U\F5FU^6*WWAE7:6F`%%I7HQL^FV*F^UF!2]045/%*,#;@8E0#FM5=)F27L]D,8*HM+\4YK]^G%!-C9*5P564`6Y1,-N"[!ZZ;3HX'^!RM-M]BVG1%C?@K)@^BI%-SB2LYJ,"4)S#8!X6G-[(Y?M0BNW=)E=K:9XTS&8W[110UU.T.*X\@6U!"8RHC]?_OW*D`B%%7AO?9**1X,R\\R;^)59*Y%(GL/8M#&RL[0()+S`KZ)&Y>3#IV]?COOIEJF,N`)BN:(!I]T'MWG/]GQ[R*(U?_-*J:(CQ&R>=EJF`[email protected]:89`9TY%,0V,_2DE95X4'T,*6"@H@2YQMJ1WW*VC9:=5K#VK)+FEU7R&@M?5I>9?>NKU]YLK""\!Z2%`3IT$/VU0'(@BH11+P0QU@)$*7>2^'/`G"*30A27H0$GRM8@&J4CBD&CIG86'-7Y"E!?L8I0>FI4'TY2=`HEJM!M`$2XXP9LFA&"_7Z0JT$CDRS.,%INI/,*5H3G![@MSBS=`HX`>*"^7+)J6^;R-_.`@YP80Z8+:N%.K^KLA"_L,3*:>1VDNIJ%-2MXY_%N-4_)P67.`IOF'J3&JD218O++5VM,8!UVD"PV8`O]`AS[:5VMQ6AO(T8!HSD02J5PI'(75>%3:((G,>55PS=;3'RJ:YR5FX>B41XQ+AKG'4%34>8Y:>Y4*LH:&LQ3''DF73M!=B?U[.JC^Q_,%@98.V0A4LK+9BVD1P9X^I$E:SCELS6E]!#^EAS'DLQ7-$#M52``=26%O,`8BU$+0]@M9.=W@7UKSQN6-G!KI7#8F59=L+T"0[`$6_F33"HEM3"H.44LBP@"C+11#RB-U'#Z$-U=4ANG#_:?X*M`E5PP$TWY[R[,.WJ>FV-FH=M%$6;R-'MUNK8&=Z!X%Z0`)J1CDW@G`^N+KGTTXK+!/#%JUU1&^G-&@')+>4"XEZ!93OWMJU/=U(*064N`U>`*&4NV.K@"5S#HX"M'TT0B=5(59M`IIFPXU0>PB(ZGKF$=OW[OX;\G##`^?7WW_>F'MO[\____^];"#`)I,M952`F"ER6P]6*/#;>$(P(,-_SI@H106%E[CRPDNR4'.`(TO::)#27)E!(!$)B7K;%QH`0!7M026!=*E??/[IIW_3,:;%8?^.>58=N)1ID["W!@M!5A06#A*V1$0C*4'TQN%"H0'O3G-R`6P^D1'K)$)#6[%8UO1'FZ*QPP5D*0NMJ(.+^GYWOFEQ:@^J7\`"H[E-2,E_N1(GP.LQS].:==U-E,_QK*&6BT$`'FM0DR[/#.=)F2E&Z+9RFP4@)J(.O^A"RYJ3F^0X((39@]BN\F@]@C]G,9F)#7$*04G`"$`RA1B8P_Q('0/M78B2EMF"@"4`@/.]A=Y4K_$+._`.H/J?C3PFI>IO$@6M7"RHE7M$YA:FB60-#7G:B%E&@H6%\"3JNOQE8QC/)J:AY1@6O""=PHFDX8DP`L$1LGAS\HE0"L41T'"18>0S(L!Q9#%&-@L3$AM=8+-(9$$PSTVMC]1R1P_2B%I03I6A4Z@'>::0VDLC6(0PG&8``[H7A#\`&RM=S@KT@(=(*-V!R6@"@K;$(I^6"+ATTJS9I2C@&IPR$H%D'BLU$DZX(?8T`N@M,44F%Z!&"![+->>]1"I*%XMS@!8]15G^D,%+MM@YHDLGI0/K&1)-9(C3JIX@A`&'E``D6%*IL";&:"%?YNSM='>M=2=JR1*1$WDL;+?_-X^FOGPW=_]%MWP'.TOR]X/L-1?^]TBD=TKFRQ@>RRP^X0).XAZ^X,$\MX#,M1O@]X@Z>WR[=RQ0NJ9[23GYH'W4U`'=+8:"QP_-B#Z`40>-+2/HS!KNGMS5`](Z:@8BU`??I6=UHM(]@G!,9-OH);+H+M3*SK2\QI"E0Z"E3I*=,3$XO=TP/S%5-08&!P,8#1`%.;[L7N!=/"CKG"@D'`M@,'",N^!F$9-#QY("/!^$1AL\3GV#00@:H^E=0C[KZ6!&O/;XHME(@*LF66A\1V.!6OP"XH(E8C%@L5LRT>F^.,U8:E8;(WRH@L6,YN"ZV'&*X%MH[%O21ALC6(Y&.*PN[XK5P8AY'-/87N5(^60`XPW`)0``,9`DG[UT%T,WVSYM#7;889.#ENMI%X,H,/1E0)$44-E!7_C_G#!>#+H$YTQT@G[LBR[`H3*R-(0ZM%T2BPR$7*:'(*#.*:T#4J2@PV&B:90?Y``DG!A/,?"8N'XM[(\F&(QCCL=39)!!D"W@"H"O7L/+$$03B1T1V11I!9%48@,U;$D,O132VR.EMO=+:63%E]D,-VJVW43EU]-3;.,E=-E:`9T5X1W&3BR&&A\MD=MS2BFOXBH)#MWG;CDRO>-^)MTSW4@WF_O=/B:EM>^8X8C:W1Z*ZW?E$#_'CP5ZAYZ4O`OPHPM,($":TH9YPKG3-``!=EA\P4WW\3`I7);;M-E#&!>DM=@`\V>`9!`$J"`8\7LM@HPH)Z_2-";)_W?6V6]`A%&I,+M(X4DT050*A#'&1%?D`/NPSM''TQM005)283"DW.L-)(,24DYKDI$V]4RF2]>9_+^O-%%K0@/4X#QN)%(?0&D"`M#I`J':6*()Q8()]#XE$[^+Q`X3DR0O44*7.75H7'S'@"P$*2Y!-3"%C,7BH.?]:ME0\"G*E?$P"``C`PZVOSNB#Y`&B3R@'"H.5E!5\060"H@^K\N5(X@,R.'[M#M;'JX2FCF((!3O9,-])P'N]]9P0JRQP*A+BT'!AMJ#\+[Z!,F?"XV:+A(&@YQM&T0$XA>!>(`B;@.P8=SB`MJXQ*F9\6N&G)L8C[3)%XYR>,6"KE4&Z+W6!$\&M7.!B&R1/P)(**P@4X*]P^BO4N('*^06CV=>N'Q"\`%A\K``;>=%$D+!A;>MYMP:[N1&I@+,:["_L.LX#4!O.TO!P?;(EY6_+"R5"5#50)Q`.H,EI=[1@>#0.4MQ^/IP!]:;/O2UU[WK3X][WY,>^,#__?!);WS=$__XJ/]\[G>O?.9#?_K+MC[[UJ2_]ZF/_^MKO?O:_;WT8P,)GXMGQU1E@`"BE>%_V>!*4,@8!6-WSKX/QM&:DMD`,$`^X*!('J`93ZS/$MC9/+Q#UU'#STP=7:!`;;T#2R`61_5@,QEM)FS7&=FP2*06,0P#)U]P,RS&/)K"/(TE@LVC*8%T=>2!1Y@4`$;G',+0/]`1M#='`#^>A1]\!-1>4%T/S_UH`L4O!E`Y*XQVN`AY\90#!-'D\T%0Q@'#>QWW@M!WTG5R`CIWH:084*RX>1>8H?(YI?!Z:$53(>18WH+EGMCBNJ>@UZ>XQ9>@0JH#>J0CBJ_Z$[:J,YZJ,\JJ"ZUZ-`*J1!VGG8-@,G=B:\MHU7U]!?_0DD,8%AWX5Y9?X8A\)]O4VS!,-#=W\Y;UL=8QYL,TZH9>6=EOM7JURMKIN#9LUC7>T:Z,SMTX776F2*_O^MGNS+>.O\`-R#"(:CW8`68@?A?IA@APL*.)][*38XXW\Z[LACC[0%B&*)M'!)&HXSY20OFK?\?JVN]2E"3]AN>#_M#O>W;RO95/M$O6[-MB*=U]K+;U]8E7OO8*LMWB]Y-XYG63>WU1B?MX'2\P2A^^6XH[VKG(;7G,"SQ3C@=:U*L^M.7TYW?.5_USB`9>P_(9]4MEB&ZA#>]Z*X:WPVJPDMBJ*M9;P:N[%ZS3?>G'YOSUHME?0#MD`LVW9^4S;95T@__%HS?$B/^1$,(SJ"[,.RH`X!I-7K")$;L=*0@U@0$4-PL5KAL_.DI]NZ#OH"2R;;MQFF#A$`&M(+$54`(BX#\T,)H?*_$1W\#V&>K@*^HGK+DSY\^>.^/C!:5TL$*%3*9%AL,&MCF6P622&ZZA:M6NXM^G.AF`;.B5$BHS[5J2;/P]N5;SKSY%>7/FT.?#"`TMZ.O6-6/?GIT[PR:#7H;D"8WC"IXG,9KG@7&G^O0G#ZM,_WD2/4N=-%68$(E_MD$FB#51`@0(*%`8`8070(%4-BS#%PR(/EG.("'2Y)0NEGE`K]*:B3)8'GTT;1K*#31A^IM]Q%*)I6W8'CJU3"3"3#%!Q98&9A0@`E.&$I!`Q%H)Z$ZF\N'OM)H[X9A7_SU-%`,)4.4PT/'+RU(JIU2RYW:59="G@""E2+`@M0VMTB0`&_M.:-OI_"@`'2R(`V`N`K!IA`M"4!0@A+`8)]1`XE%&M&1"IRJCA'02_^VA.($,1%A"-080@"&(+V;):(\,NE*MAKS2%%[H0>I)3BIU]M@>?WXK!@9FIF6,?J)N&P20H2BR8[F+"$1EL\B#MO/`.$&=-H7$-ZFQO&I@`UOV4=00(B:%M\Z\^&>Q@:W+R83Q/C'6V0MB/$%!J)/"'^X20-34!:4&!GL06WF*(MZ1*53